Investigate the Efficacy and Safety of Farudodstat Compared With Its Placebo in Adult Alopecia Areata Participants
Status:
Recruiting
Trial end date:
2024-04-18
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to measure the efficacy of farudodstat compared to placebo
at Week 12 from the treatment start, in adult participants with Alopecia Areata (AA) with 50%
or greater scalp hair loss.